Segment Information by Division

January 1 to December 31

Download

€ million

Silicones

Polymers

Biosolutions

Polysilicon

Other

Consolidation

Group

2023

External sales

2,741.3

1,562.0

337.2

1,599.3

162.4

–

6,402.2

Internal sales

0.1

17.8

–

-17.9

–

Total sales

2,741.4

1,579.8

337.2

1,599.3

162.4

-17.9

6,402.2

EBIT

101.6

203.0

-20.1

203.3

-82.4

-0.5

404.9

Depreciation/amortization

134.8

50.1

26.6

117.3

89.9

–

418.7

EBITDA

236.4

253.1

6.5

320.6

7.5

-0.5

823.6

EBIT includes: result from investments in joint ventures and associates

3.9

–

45.4

–

49.3

Impairment of fixed assets

–

Asset additions¹

241.4

74.1

155.5

165.1

73.5

–

709.6

Additions to financial assets

–

0.6

–

0.6

Asset additions

241.4

74.1

155.5

165.1

74.1

–

710.2

Assets (Dec. 31)

2,499.6

948.1

762.6

981.3

3,662.9

-0.1

8,854.4

Liabilities (Dec. 31)

1,079.4

402.6

239.1

761.6

1,791.9

-0.1

4,274.5

Net assets (Dec. 31)

1,420.2

545.5

523.5

219.7

1,871.0

–

4,579.9

Investments in joint ventures and associates included in net assets (Dec. 31)²

97.8

–

857.4

–

955.2

Research and development expenses

72.3

34.3

5.5

33.5

38.5

–

184.1

Employees (Dec. 31)

6,040

1,622

1,191

2,322

5,203

–

16,378

Employees (average)

6,087

1,612

1,109

2,298

5,145

–

16,251

2022

External sales

3,452.8

1,967.7

331.1

2,287.2

170.5

–

8,209.3

Internal sales

0.1

28.5

–

-28.6

–

Total sales

3,452.9

1,996.2

331.1

2,287.2

170.5

-28.6

8,209.3

EBIT

752.8

238.3

-4.7

705.3

-13.5

0.6

1,678.8

Depreciation/amortization

123.6

50.4

21.4

120.4

86.3

–

402.1

EBITDA

876.4

288.7

16.7

825.7

72.8

0.6

2,080.9

EBIT includes: result from investments in joint ventures and associates

76.5

–

124.4

–

200.9

Impairment of fixed assets

–

Asset additions¹

199.8

107.3

102.6

91.9

45.2

–

546.8

Additions to financial assets

–

0.5

–

0.5

Asset additions

199.8

107.3

102.6

91.9

45.7

–

547.3

Assets (Dec. 31)

2,699.5

1,021.3

469.5

991.8

4,219.4

-0.1

9,401.4

Liabilities (Dec. 31)

1,128.1

450.0

184.2

692.5

1,916.1

-0.2

4,370.7

Net assets (Dec. 31)

1,571.4

571.3

285.3

299.3

2,303.3

0.1

5,030.7

Investments in joint ventures and associates included in net assets (Dec. 31)

124.2

–

875.3

–

999.5

Research and development expenses

70.9

35.2

4.8

27.0

40.5

–

178.4

Employees (Dec. 31)

6,019

1,603

835

2,283

4,985

–

15,725

Employees (average)

5,790

1,595

790

2,207

4,880

–

15,262

¹	Intangible assets; property, plant and equipment; investment property; excluding right-of-use assets.
²	Includes assets held for sale. The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 22.

Annual Report 2023

Segment Information by Division

Related Links

We Invest in People